Home » SkyePharma Completes Enrollment for Flutiform Efficacy Trials
SkyePharma Completes Enrollment for Flutiform Efficacy Trials
UK drugmaker SkyePharma has enrolled all patients in three double-blind efficacy trials for Flutiform, an asthma treatment.
The three trials involve approximately 1,400 patients and will provide data for the new drug application in the U.S. and a European marketing authorization application.
SkyePharma said it anticipates completing the trials in April 2008.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May